Navigation Links
DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
Date:6/8/2013

Chicago, IL (PRWEB) June 08, 2013

The birth control information center at DrugRisk.com is announcing new information on the site for women who have taken the contraceptives Yaz or Yasmin. Records show the number of pending cases filed alleging blood clots has decreased as Bayer reserves compensation for victims*.

DrugRisk was created to improve the safety of patients taking popular prescription drugs like Yaz and Yasmin, by providing the latest research, safety alerts, recalls and litigation news. Visitors can determine if others have experienced similar side effects and decide if they need legal advice.

The resource center has added warnings from health experts like the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots.

Due to the number of patients that have filed a Yaz lawsuit alleging blood clots, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).

DrugRisk has learned that Bayer has spent nearly $1 billion so far to settle around 4,800 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)****. They have also committed up to $1.5 billion to resolve all the cases*****.

Now, the resource center has learned that the latest court update from the Judicial Panel on Multidistrict Litigation shows the number of filed claims has fallen to 9,961*.

Lawyers are still helping those who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin. Anyone affected is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

Due to the specialized nature of federal MDL drug injury litigation, DrugRisk cautions that patients should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*JPML 5/15/13; jpml.uscourts.gov/sites/jpml/files/Pending%20MDL%20Dockets_By%20District_May-14-2013.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer 2/28/13; annualreport2012.bayer.com/en/legal-risks.aspx
*****Reuters, 3/4/13; newsandinsight.thomsonreuters.com/Legal/News/2013/03_-_March/Bayer_reserves_$1_5_bln_to_cover_Yasmin,_Yaz_lawsuits/

Read the full story at http://www.prweb.com/releases/yaz-side-effects/settlement-values/prweb10812345.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
2. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
3. DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits
4. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
5. DrugRisk News: Federal Panel Issues Latest Mirena Lawsuit Updates
6. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
7. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
8. DrugRisk Update: Byetta Maker Agrees With Transferring Lawsuits to Federal Court
9. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
10. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
11. DrugRisk Update: New Study Warns of Cancer in Byetta Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
Breaking Medicine Technology: